Schwartz-Matsuo Syndrome Secondary to Chronic Rhegmatogenous Retinal Detachment: Outer Retinal Corrugations as Novel Diagnostic Biomarker of a Challenging Entity.
Schäfer, Malclès … Bravetti
Ocul Immunol Inflamm·Apr 1, 2026
This case report identifies outer retinal corrugations on OCT as a novel diagnostic biomarker for Schwartz-Matsuo syndrome, a rare condition combining chronic rhegmatogenous retinal detachment, anterior chamber inflammation, and elevated IOP.
Postoperative Epiretinal Membrane After Fovea-sparing Versus Standard Internal Limiting Membrane Peeling for Myopic Traction Maculopathy.
Shiraki, Shiraki …
Am J Ophthalmol·Apr 1, 2026
Fovea-sparing ILM peeling (FSIP) for myopic traction maculopathy resulted in a significantly higher incidence of postoperative epiretinal membrane formation (17.4%) compared to standard ILM peeling (5.0%), though most ERMs were subclinical and did not affect visual outcomes.
Vitreous Hemorrhage Due to Posterior Vitreous Detachment: Incidence of Retinal Detachment and Spontaneous Clearance during Observation.
Hasbolat, Christensen & Lund-Andersen
Ophthalmology·Apr 1, 2026
In patients with vitreous hemorrhage from posterior vitreous detachment, 62% cleared spontaneously while 17% developed rhegmatogenous retinal detachment, with most detachments occurring within the first 3 weeks.
Incidence and Associated Factors of Myopic Maculopathy Progression after Posterior Scleral Contraction in High Myopia.
Zhao, Zhao … Hu
Ophthalmology·Apr 1, 2026
In high myopia patients undergoing posterior scleral contraction, 10.76% developed myopic maculopathy progression despite surgical improvements in visual acuity and axial length, with steeper corneal curvature and higher IOP being key risk factors.
Epidemiology, Clinical Features, and Visual Outcomes After Intraocular Foreign Body Removal: An IRIS® Registry Analysis.
Ong, Goldberg …
Ophthalmol Retina·Apr 1, 2026
Large IRIS Registry analysis of 4,784 eyes with intraocular foreign bodies found significant visual improvement beginning at 2 months post-removal, with worse outcomes associated with endophthalmitis, retinal detachment, hyphema, and Black/African American race.
Rhegmatogenous Retinal Detachment in Stickler Syndrome: A Systematic Review and Meta-Analysis.
Alsharif, Alwisi … Abu Serhan
Ophthalmol Retina·Apr 1, 2026
This systematic review and meta-analysis of 49 studies involving 3,492 individuals found that rhegmatogenous retinal detachment affects 41.9% of patients with Stickler syndrome, but prophylactic treatment reduces this risk by 92%.
SOCIODEMOGRAPHIC FACTORS AS PREDICTORS OF DIABETIC RETINOPATHY SCREENING: A Systematic Review.
Butt, Ahmed … Kohly
Retina·Apr 1, 2026
This systematic review of 33 studies involving over 100,000 participants found that sociodemographic factors significantly influence diabetic retinopathy screening adherence, with older age, higher education, higher income, and private insurance associated with better compliance.
Reply to Comment on: Choroidal-Derived Intraretinal Neovascularization Compensates for Diabetic Retinopathy Ischemia via Dual-Pathway Remodeling Post-PRP.
He, Guo … Pan
Am J Ophthalmol·Apr 1, 2026
Abstract not available — see full article for details.
Comment on: Choroidal-derived intraretinal neovascularization compensates for diabetic retinopathy ischemia via dual-pathway remodeling post-pan-retinal photocoagulation.
Kakihara & Fawzi
Am J Ophthalmol·Apr 1, 2026
Abstract not available — see full article for details.
THE EFFICACY AND SAFETY OF SUBRETINAL BALANCED SALT SOLUTION INJECTION IN DIABETIC MACULAR EDEMA WITH HARD EXUDATES.
Li, Li & Cun
Retina·Apr 1, 2026
Subretinal balanced salt solution injection using a 40-gauge curved needle combined with vitrectomy and ILM peeling significantly improved visual acuity, macular thickness, and hard exudate resolution in diabetic macular edema patients compared to vitrectomy alone.
DRSPLUS RETINOGRAPHER IN PATIENTS WITH DIABETES: A Comparison Study by Consensus Grading, Reading Center, and Artificial Intelligence.
Parravano, Costanzo … Querques
Retina·Apr 1, 2026
The DRSplus retinographer achieved >80% gradable image rates in nonmydriatic diabetic retinopathy screening, with AI demonstrating 97.3% sensitivity for detecting referable DR compared to reading center grading.
Foveal Avascular Zone Enlargement Significantly Improves Statistical Models for Detection of Diabetic Retinopathy Severity.
Busza, Duffy … Fawzi
Ophthalmol Retina·Apr 1, 2026
A novel metric combining OCT angiography parameters with foveal avascular zone (FAZ) enlargement significantly improves statistical models for detecting high-risk diabetic retinopathy, achieving AUCs of 0.91 for referable DR and 0.82 for proliferative DR.
Brolucizumab for Diabetic Macular Edema in Participants with/without prior Anti-VEGF Exposure: KINGFISHER Study Post Hoc Analysis.
Ip, Chaudhary … Singer
Ophthalmol Retina·Apr 1, 2026
Post hoc analysis of KINGFISHER study demonstrates that brolucizumab 6mg provides effective treatment for diabetic macular edema regardless of prior anti-VEGF exposure, with superior anatomical outcomes compared to aflibercept 2mg in both treatment-naive and previously treated patients.
Towards an Era of Oculomics: The Relationship Between Baseline Severity of Diabetic Retinopathy and Risk of Mortality.
Lee, Marwah …
Ophthalmology·Mar 31, 2026
This large retrospective cohort study of over 500,000 diabetic patients found that baseline diabetic retinopathy severity is independently associated with increased mortality risk, with proliferative DR patients having more than double the death rate compared to diabetics without retinopathy.
Racial and Ethnic Differences in Prevalence and Incidence of Diabetic Retinal Disease.
Goblirsch, Yu … VanderBeek
Retina·Mar 31, 2026
This 22-year retrospective cohort study of US diabetes patients reveals persistent racial disparities in diabetic retinal disease, with Hispanic patients now showing the highest prevalence rates (26.0% in 2021) and Black/African American patients consistently maintaining elevated rates compared to White patients.
Impact of Baseline BCVA on Outcomes with Aflibercept 8 mg in Patients with DME.
Javaheri, Vakharia … Do
Ophthalmol Retina·Mar 30, 2026
Aflibercept 8 mg showed equivalent visual and anatomic outcomes compared to 2 mg in diabetic macular edema patients at 96 weeks, with efficacy maintained regardless of baseline visual acuity.
Modest and Variable Correlations Between Geographic Atrophy Enlargement Rates in Fellow Eyes in the AREDS2 Study.
von der Emde, Vance …
JAMA Ophthalmol·Apr 2, 2026
Analysis of 386 eyes with bilateral geographic atrophy from AREDS2 found only modest correlations in enlargement rates between fellow eyes (r=0.11-0.51 depending on measurement method), challenging assumptions used in clinical trial designs.
Reduced Risk of Non-Neovascular AMD in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Propensity-Matched Cohort Study.
Lishinsky-Fischer, Gharra … Levy
Am J Ophthalmol·Apr 1, 2026
A large retrospective cohort study of 72,074 cancer patients found that immune checkpoint inhibitor therapy was associated with a 23% reduced risk of developing non-neovascular AMD over 5 years, with no effect on neovascular AMD risk.
Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration: Two-Year Efficacy and Safety Results from the GATHER2 Phase 3 Trial.
Khanani, Danzig …
Ophthalmology·Apr 1, 2026
Avacincaptad pegol (ACP) 2mg demonstrated sustained reduction in geographic atrophy growth over 2 years, with both monthly and every-other-month dosing showing 14% and 19% reduction respectively compared to sham treatment.
Levodopa and Dopamine Agonists in Neovascular Age-Related Macular Degeneration in the Sight Outcomes Research Collaborative Database.
Chan, Congivaram …
Ophthalmol Retina·Apr 1, 2026
This retrospective cohort study found that levodopa exposure was associated with a 47% reduced likelihood of conversion from nonneovascular to neovascular AMD over 5 years, while other dopamine agonists showed no protective effect.
MEASUREMENT OF CHOROIDAL VASCULARITY INDEX AND CHOROIDAL THICKNESS USING DEEP LEARNING-BASED METHODS WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY.
Arkan, Cakır … Mercan
Retina·Apr 1, 2026
A deep learning-based convolutional neural network successfully automated measurement of choroidal thickness and choroidal vascularity index from swept-source OCT images with high accuracy (96.9%) and excellent correlation with expert ophthalmologist measurements (ICC 0.987).
INCIDENCE AND ENLARGEMENT RATE OF MYOPIC MACULAR NEOVASCULARIZATION-RELATED ATROPHY IN HIGHLY MYOPIC EYES.
Moukadem, Motloch … Couturier
Retina·Apr 1, 2026
In highly myopic eyes without preexisting RPE atrophy, one-third develop MNV-related atrophy within 2 years of MNV onset, with an annual enlargement rate of 0.22 mm²/year.
VITRECTOMY WITH SUBRETINAL TENECTEPLASE AND INTRAVITREAL CONBERCEPT FOR SUBMACULAR HEMORRHAGE: A Prospective Interventional Study.
Cui, Zhen & Si
Retina·Apr 1, 2026
A combined vitrectomy technique using subretinal tenecteplase, intravitreal conbercept, and gas tamponade achieved favorable visual outcomes in 75% of patients with submacular hemorrhage, with earlier intervention showing better results.
Glucagon-Like Peptide-1 Receptor Agonist Use and Risk of Neovascular Age-Related Macular Degeneration in a National Cohort Study.
Allan, Cohn … Rachitskaya
Ophthalmol Retina·Apr 1, 2026
GLP-1 receptor agonists were associated with reduced risk of both nonneovascular and neovascular AMD development compared to other glucose- and lipid-lowering medications in this large retrospective cohort study of patients over 60 years.
Efficacy and Safety of the Proposed Biosimilar Aflibercept, SDZ-AFL, in Patients With Neovascular Age-Related Macular Degeneration: 52-Week Results From the Phase 3 Mylight Study: Erratum.
Bordon, Kaiser … Silva
Retina·Mar 31, 2026
Abstract not available — see full article for details.
Ellipsoid zone integrity at angiographic leak following resolution of central serous chorioretinopathy: MICRoN report number Two.
Hasan, Zarnegar …
Retina·Mar 30, 2026
In resolved central serous chorioretinopathy eyes with perifoveal angiographic leak, longer symptom duration and complex CSCR are associated with increased risk of ellipsoid zone atrophy following resolution.
CLINICAL AND IMAGING PREDICTORS OF BILATERAL INVOLVEMENT IN CENTRAL SEROUS CHORIORETINOPATHY.
Okur, Simsek … Artunay
Retina·Apr 1, 2026
This retrospective study of 63 patients with complex central serous chorioretinopathy identified smoking, CSCR-related changes on baseline fluorescein angiography of the fellow eye, and reduced subfoveal choroidal thickness in the affected eye as independent predictors of bilateral disease development.
COMPARISON OF FOVEA-SPARING (BUTTON-HOLE) AND CONVENTIONAL INTERNAL LIMITING MEMBRANE PEELING IN RETINAL ARTERIAL MACROANEURYSM RUPTURE: Visual and Anatomical Outcomes.
Chae, Kim & Lee
Retina·Apr 1, 2026
Foveal-sparing (button-hole) ILM peeling demonstrated superior visual outcomes and eliminated postoperative macular hole formation compared to conventional ILM peeling in patients with retinal arterial macroaneurysm rupture.
High Yield of Systemic Workup in Patients with Acute Isolated Paracentral Acute Middle Maculopathy.
Hostovsky, Peled … Fogel Levin
Ophthalmology·Apr 1, 2026
Systematic workup of patients with acute isolated paracentral acute middle maculopathy (iPAMM) revealed abnormal findings in 64% of cases, with particularly high yield in patients over 65 years old (87.5%).
IMPACT OF SLEEP APNEA ON RETINAL VEIN OCCLUSION IN INDIVIDUALS 55 AND YOUNGER: A Retrospective Cohort Study.
Shmushkevich, Berzack … Williams
Retina·Apr 1, 2026
Sleep apnea increases the risk of retinal vein occlusion by approximately 22% in adults ≤55 years, primarily through increased branch RVO risk rather than central RVO.
THE EFFECT OF PREECLAMPSIA SEVERITY ON CHORIORETINAL MICROVASCULAR CIRCULATION: A Pilot Prospective Optical Coherence Tomography Angiography Study.
Özer Özcan, Güngör & Özcan
Retina·Apr 1, 2026
This OCT angiography study of 66 preeclamptic patients found that severe preeclampsia causes greater reduction in deep capillary plexus and peripapillary vessel density compared to mild disease, with slower postpartum recovery despite improvement in both groups.
Risk Factors and Systemic Outcomes in Patients with Retinal Artery Occlusion.
Knapp, Schulgit … Srivastava
Ophthalmol Retina·Apr 1, 2026
In this retrospective study of 596 patients with acute retinal artery occlusion, stroke or MI occurred in only 1.51% within one week and 13.3% over long-term follow-up, with no difference in outcomes between emergency room and outpatient evaluations despite more intensive workups in the ER setting.
EPIRETINAL MACROPHAGE-LIKE CELL ALTERATIONS FOLLOWING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN BRANCH RETINAL VEIN OCCLUSION WITH MACULAR EDEMA: A Retrospective Longitudinal Study.
Bai, Zhao … Yao
Retina·Apr 1, 2026
Anti-VEGF therapy reduces epiretinal macrophage-like cells (eMLC) in BRVO-ME patients, with greater reduction in early responders receiving three injections compared to limited responders or fewer injections.
Recurrent combined branch retinal vein and branch retinal artery occlusion associated with PAMM as the first manifestation of lung adenocarcinoma: a case report.
Essassi, Nabi … Khairallah
J Ophthalmic Inflamm Infect·Mar 31, 2026
A 54-year-old male presented with recurrent bilateral combined branch retinal vein and artery occlusions with PAMM as the initial manifestation of lung adenocarcinoma, associated with elevated antiphospholipid antibodies that normalized after tumor resection and chemotherapy.
Unilateral Retinal Pigment Epithelium Dysgenesis (URPED) - The Expanded Spectrum and New Insights from Multimodal Imaging.
Trinco, Romano … Pellegrini
Am J Ophthalmol·Apr 1, 2026
This multicenter case series of 10 patients demonstrates that unilateral retinal pigment epithelium dysgenesis (URPED) encompasses a broader phenotypic spectrum than previously recognized, including covert forms detectable only on indocyanine green angiography, with frequent associations with hamartomatous lesions and choroidal neovascularization.
Geographic and Phenotypic Variability in RHO-Associated Retinopathy: Evidence From a Chinese Cohort and Global Literature.
Hang, Zhao … Sun
Am J Ophthalmol·Apr 1, 2026
This large cohort study of 2,196 patients with RHO-associated retinopathy reveals significant geographic variation in common variants and demonstrates that biological classification predicts disease severity, with R135W emerging as a particularly aggressive variant.
MODELING NATURAL HISTORY AND COST-EFFECTIVENESS OF GENE-AGNOSTIC TREATMENT IN RETINITIS PIGMENTOSA.
Sullivan, Wertheimer … Jayasundera
Retina·Apr 1, 2026
A cost-effectiveness analysis found that a hypothetical gene-agnostic therapy for retinitis pigmentosa, priced at $1.5 million for both eyes, may be cost-effective with an ICER of $158,554/QALY, particularly when initiated early at age 30.
Long-term Progression of Ellipsoid Zone Loss and Associated Features on OCT in Macular Telangiectasia Type 2.
Raming, Goerdt … Pfau
Ophthalmology·Apr 1, 2026
In macular telangiectasia type 2, ellipsoid zone loss follows a sigmoid progression pattern over 30-40 years, with morphologic pattern being the strongest predictor of disease acceleration beyond 0.5 mm² of loss.
COMPARING THE ABILITY OF GENETIC TESTING TO PROVIDE A DEFINITIVE DIAGNOSIS IN PATIENTS WITH PERIPHERAL AND MACULAR INHERITED RETINAL DISEASE.
Dones, Bou Ghanem … Brantley
Retina·Apr 1, 2026
Patients with inherited macular retinal disease are significantly less likely to receive definitive genetic testing results compared to those with peripheral retinal disease, with macular patients having 58% lower odds of obtaining conclusive genetic diagnoses.
Expanding the Clinical and Genetic Spectrum of TTLL5-Associated Retinal Dystrophy: A Single-Center Cohort Study.
Zhou, Liu … Sui
Ophthalmol Retina·Mar 31, 2026
This retrospective cohort study of 21 patients expands the phenotypic spectrum of TTLL5-associated retinal dystrophy to include cone dystrophy, cone-rod dystrophy, and rod-cone dystrophy, with high myopia being a consistent feature across all phenotypes.
Ultra-Widefield Examination of the Peripheral Retina in BEST1 -related retinopathy.
Parodi, Mansour … Antropoli
Retina·Mar 31, 2026
Ultra-widefield imaging reveals that BEST1-related retinopathies are associated with significantly more peripheral retinal changes than controls, particularly white/dark without pressure and vascular abnormalities.
Precision Risk Model Using Quantitative Assessment of Vascular Severity in Telemedicine-Based Screening.
Placide, Coyner … Campbell
JAMA Ophthalmol·Apr 2, 2026
A precision risk model incorporating gestational age, postmenstrual age, and vascular severity assessment successfully predicted treatment-requiring ROP within 2 weeks, potentially reducing screening examinations by 28-39% while maintaining 100% sensitivity.
Surgical and Observational Outcomes in Optic Pit Maculopathy: A Comparative Analysis of Pediatric and Adult Populations.
Barresi, Chapron … Abdelmassih
Ophthalmol Retina·Apr 1, 2026
Surgical management of optic pit maculopathy achieves significant anatomical and visual improvements in both pediatric and adult patients, with 66.7% anatomical success rate and meaningful BCVA improvement from 0.92 to 0.44 logMAR.
WIDE-FIELD RETINAL AND CHOROIDAL THICKNESS IN HEALTHY CHINESE CHILDREN: Normative Ranges and Influencing Factors.
Zhou, Zhao … Wu
Retina·Apr 1, 2026
This cross-sectional study of 2,032 healthy Chinese children aged 7-19 years established normative ranges for wide-field retinal and choroidal thickness using OCT, finding that choroidal thickness decreases with age and myopia severity while retinal thickness remains relatively stable.
Ultra-Widefield Indocyanine Green Angiography in Uveitis.
De Simone, Genovese … Cimino
Ocul Immunol Inflamm·Apr 1, 2026
Ultra-widefield indocyanine green angiography (UWF-ICGA) detected peripheral retinochoroidal lesions beyond the vortex veins in 71.4% of uveitis cases, with the highest detection rates in ampiginous choroiditis and vasoproliferative tumors (100%).
Combined PCR Positivity for <i>Mycobacterium tuberculosis</i> Complex and Nontuberculous <i>Mycobacterium</i> Species in Patients Treated for Tubercular Panuveitis.
Kelgaonkar, Nayak … Behera
Ocul Immunol Inflamm·Apr 1, 2026
Dual infection with Mycobacterium tuberculosis complex and nontuberculous mycobacteria occurred in 4.11% of tubercular uveitis patients, presenting as severe bilateral panuveitis with universal optic atrophy but responding well to standard anti-tubercular therapy.
Uveitis Associated with Protein Kinase Inhibitors in Cancer Patients: A Risk-Based Ophthalmologic Management.
Abbouda, Barone … Appolloni
Ocul Immunol Inflamm·Apr 1, 2026
Uveitis has been reported with 18 of 71 FDA-approved protein kinase inhibitors (PKIs), most commonly vemurafenib, with anterior uveitis being the predominant phenotype requiring interdisciplinary management to preserve vision while maintaining cancer therapy.
Acute Retinal Necrosis Presenting with Exudative Retinal Detachment: Clinical Features and Outcomes.
Watane, Nasir … Tyagi
Ocul Immunol Inflamm·Apr 1, 2026
Exudative retinal detachment (ERD) occurs in 4.34% of acute retinal necrosis (ARN) cases and indicates severe disease with extensive quadrantic involvement and high rates of occlusive vasculitis.
Evaluation of Optical Coherence Tomography Angiography Parameters in Pulmonary, Ocular and Extrapulmonary Sarcoidosis.
Hepokur, Usta Küçükbezirci … Uçar
Ocul Immunol Inflamm·Apr 1, 2026
OCTA revealed selective reduction in deep capillary plexus vessel density in sarcoidosis patients compared to controls, even in those without clinical ocular involvement, suggesting subclinical microvascular compromise.
Incidence of Cataract Surgery and Postoperative Visual Acuity Outcomes in Patients with Vogt-Koyanagi-Harada Disease.
Sittivarakul, Chantinmathorn … Ratanasukon
Ocul Immunol Inflamm·Apr 1, 2026
VKH patients have a 27.9% cumulative incidence of cataract surgery at 5 years, with substantial visual improvement following surgery, particularly in patients receiving systemic immunomodulatory therapy.
Comparative Clinical Features, Vascular Complications, and Outcomes in CMV Retinitis: Pediatric vs HIV Positive and HIV Negative Adults.
Bezci Aygun, Ulutaş & Kadayıfcılar
Ocul Immunol Inflamm·Apr 1, 2026
CMV retinitis presents with distinct clinical patterns across patient populations, with pediatric patients showing more severe bilateral disease and higher retinal detachment rates compared to HIV-positive and HIV-negative adults.
Characteristics Associated with Appointment No-Show at an Academic Uveitis Service.
Kong, Ortiz-Whittingham … Williams
Ocul Immunol Inflamm·Apr 1, 2026
In a retrospective cohort study of 1,081 uveitis patients, 36.4% had at least one no-show appointment, with younger age, Black race, Medicaid insurance, and blindness identified as significant risk factors for appointment non-attendance.
Clinical Features and Treatment Outcomes of Patients with Tubulointerstitial Nephritis and Uveitis Syndrome: A Case Series.
Ruiz-Lozano, Liberman … Perez
Ocul Immunol Inflamm·Apr 1, 2026
This retrospective study of 27 TINU syndrome patients found that 52% had intermediate/posterior segment involvement beyond anterior uveitis, with 50% experiencing disease relapse despite treatment, indicating most patients require long-term immunosuppressive therapy.
Clinical Features and Risk Factors for Chronic Syphilitic Uveitis.
Sureshkumar, Song … Lobo-Chan
Ocul Immunol Inflamm·Apr 1, 2026
A retrospective study of 54 patients with syphilitic uveitis found that 37% developed chronic inflammation, with cystoid macular edema (CME) at diagnosis and longer symptom duration being significant risk factors for chronicity.
Oral Valacyclovir Effectively Treating Acute Retinal Pigment Epithelitis in Cases Unresponsive to Oral Steroids Alone.
Chavan, T & Sr
Ocul Immunol Inflamm·Apr 1, 2026
Oral valacyclovir successfully treated three cases of acute retinal pigment epithelitis (ARPE) that failed to respond to systemic steroids alone, resulting in visual improvement and outer retinal layer regeneration on OCT.
The Probability of Detecting Sarcoidosis in Uveitis Patients with Intermittent Tattoo Swelling: A Retrospective Analysis.
Dimitroff, Ahmed … Swan
Ocul Immunol Inflamm·Apr 1, 2026
Among uveitis patients with intermittent tattoo swelling, 34.9% were diagnosed with sarcoidosis, suggesting this clinical finding should prompt sarcoidosis workup including chest CT imaging.
Vogt-Koyanagi-Harada Disease in Paediatric Population: Case Series and Literature Review.
Akgun, Karahan … Guven
Ocul Immunol Inflamm·Apr 1, 2026
This case series of seven pediatric VKH patients (ages 3-17) demonstrates that cataract and glaucoma are the most common complications, with adalimumab showing promise as an effective treatment option for refractory cases.
Spectrum of Ocular Manifestations in Anti-Synthetase Syndrome: A Case Report and Systematic Review.
Sriranganathan, Dhillon … Gottlieb
Ocul Immunol Inflamm·Apr 1, 2026
This case report describes the first documented occurrence of bilateral panuveitis with occlusive retinal vasculitis in anti-synthetase syndrome, representing one of the most severe ophthalmic presentations of this rare autoimmune disorder.
Adalimumab-Induced Changes in NK Cells Phenotype, Receptors, and Functions After Clinical Remission of Behçet's Uveitis.
Esen, Kokoglu … Aktas Cetin
Am J Ophthalmol·Apr 1, 2026
Adalimumab treatment for Behçet's uveitis rebalances NK cell activating/inhibitory receptors and shifts cells toward an exhausted-like phenotype, paralleling clinical improvement and suggesting NK receptor balance as a potential biomarker for treatment response.
Exploring the Association Between Autoimmune and Inflammatory Diseases and Uveitis.
Mohan, Srivastava … Sharma
Am J Ophthalmol·Apr 1, 2026
This large retrospective study demonstrates strong bidirectional associations between 12 immune-mediated inflammatory diseases (IMIDs) and uveitis, with ankylosing spondylitis, juvenile idiopathic arthritis, and systemic vasculitis showing the highest risk ratios.
Noncancerous Monogenic Mimics of Noninfectious Posterior Uveitis.
Anas, Browning … Pulido
Am J Ophthalmol·Apr 1, 2026
This consensus review emphasizes the critical importance of differentiating inherited retinal diseases from noninfectious posterior uveitis to avoid inappropriate immunosuppressive therapy and prevent vision loss.
Immunopathology of the Outer Retina: Crosstalk With the Immune System.
Wildner, Gehrke & Strauß
Am J Ophthalmol·Apr 1, 2026
Stressed retinal pigment epithelium (RPE) cells upregulate the transcription factor FoxP3 and inflammatory cytokines, then rapidly re-establish immune privilege through FoxP3-mediated mechanisms similar to regulatory T cells.
En Face Optical Coherence Tomography and OCT Angiography in the Pathoanatomy of Inflammatory Macular Disease.
Feo & Sarraf
Am J Ophthalmol·Apr 1, 2026
En face OCT and OCTA provide disease-specific imaging signatures that enhance diagnostic accuracy and management of inflammatory macular diseases by revealing layer-specific structural and vascular alterations.
New Insights into Imaging Patterns of Autoimmune Retinopathies: A Cluster-Based Update.
De Simone, Bruno … Cimino
Am J Ophthalmol·Apr 1, 2026
Multimodal imaging analysis of 10 autoimmune retinopathy patients identified three distinct phenotypic clusters that may help characterize the heterogeneity of this condition.
Clinical Assessment of a Highly Multiplexed Panel Assay for the Diagnosis of Infectious Uveitis.
Bispo, Belanger … Sobrin
Am J Ophthalmol·Apr 1, 2026
A novel highly multiplexed pan-ocular-pathogen panel (OcuPan) assay demonstrated 50.9% sensitivity and 100% specificity for diagnosing infectious uveitis, with excellent agreement with PCR and ability to detect 46 ocular pathogens in a single 12-hour test.
Assessment of Missed Appointments at a Tertiary Referral Ocular Immunology Clinic.
Kim, Manikandan & Berkenstock
Ocul Immunol Inflamm·Mar 31, 2026
Male patients and those using topical corticosteroids for active uveitis are significantly more likely to exhibit recurrent no-show patterns at a tertiary ocular immunology clinic, suggesting targeted interventions may improve adherence in these high-risk groups.
Biologics Use Disparities in Non-Infectious Uveitis: A National Study of Social Determinants of Health.
Kamyab, Mosenia … Crowell
Ocul Immunol Inflamm·Mar 30, 2026
A national study of 2,911 non-infectious uveitis patients found significant disparities in biologic therapy access, with uninsured patients having 77% lower odds of receiving treatment and insurance status being the strongest predictor of biologic use.
IL-16 in Vitreoretinal Lymphoma: First Vitreous Detection and a Preliminary Longitudinal Observation.
Saturno, Iannetta … de Smet
Ocul Immunol Inflamm·Apr 3, 2026
This case report documents the first detection of interleukin-16 (IL-16) in vitreous fluid of a patient with vitreoretinal lymphoma, suggesting it may serve as an additional biomarker alongside IL-10 for diagnosis and monitoring treatment response.
Placoid Macular Lesion as an Atypical Presentation of Vitreoretinal Lymphoma Mimicking Autoimmune Retinopathy.
Bruno, Gozzi … Cimino
Ocul Immunol Inflamm·Apr 2, 2026
A case report demonstrates that vitreoretinal lymphoma can present with placoid hyperautofluorescent macular lesions mimicking autoimmune retinopathy, with CSF molecular analysis providing crucial diagnostic confirmation when vitreous biopsy is negative.
Early Peripapillary and Macular Microvascular Changes Following Ruthenium-106 Plaque Brachytherapy For Uveal Melanomas.
Abdelkader, Salah … Abdullatif
Am J Ophthalmol·Apr 1, 2026
OCTA detected early subclinical microvascular changes following Ru-106 plaque brachytherapy for uveal melanoma, with radial peripapillary capillary density loss correlating strongly with optic nerve radiation dose and visual decline.
CLINICAL CHARACTERISTICS AND MANAGEMENT OUTCOMES OF SECONDARY TUMOR-ASSOCIATED NEOVASCULARIZATION IN RETINOBLASTOMA PATIENTS.
Fu, Yang … Ji
Retina·Apr 1, 2026
Secondary tumor-associated neovascularization (STN) developed in 12 eyes of retinoblastoma patients, primarily after intra-arterial chemotherapy, with intravitreal anti-VEGF injections achieving neovascularization control in most cases despite significant complications.
The Role of Geography in United States Retinoblastoma Care.
Shah, Pathuri … Dersch
Am J Ophthalmol·Mar 31, 2026
Geographic location significantly influences retinoblastoma treatment patterns and modifies ethnoracial and socioeconomic disparities in care, with metropolitan patients having lower odds of receiving enucleation and chemotherapy.
Endophthalmitis, surgical complications, drug safety, adverse events
RE: Bondok et al.: Sociodemographic Reporting in Artificial Intelligence Studies of Retinal Diseases: A Critical Appraisal of The Literature (Ophthalmology Retina. 2025; 12: 1133-1139).
Bair & Zafar
Ophthalmol Retina·Apr 2, 2026
Abstract not available — see full article for details.
Reply to "Letter to Editor: '6/0 PROLENE DOUBLE-FLANGED INTRAOCULAR LENS SUTURELESS SCLERAL FIXATION WITH A 27-GAUGE NEEDLE FOR INTRAOCULAR LENS SURGERY.
Pao & Chen
Retina·Apr 1, 2026
Abstract not available — see full article for details.
A novel OCT finding termed the "bucket handle sign" was identified in 8.2% of post-endophthalmitis patients, representing bullous internal limiting lamina separation with characteristic hyper-reflective band morphology.
CHARACTERIZING INTRAOCULAR LENS POSITION, STABILITY, AND IRIS MOBILITY IN EYES THAT HAVE UNDERGONE SUTURELESS INTRASCLERAL HAPTIC FIXATION.
Trese, Cdos … Wolfe
Retina·Apr 1, 2026
Ultrasound biomicroscopy analysis of 22 sutureless intrascleral haptic-fixated IOLs (SIS-IOLs) showed they position more posteriorly than standard posterior chamber IOLs and demonstrate increased iris mobility over time.
Clinical Features Associated with Poor Prognosis in Endogenous Endophthalmitis: New Insights from a 5-Year Retrospective Study.
Teoh, Abdul Jalal … Rahmat
Ocul Immunol Inflamm·Apr 1, 2026
A 5-year retrospective study of endogenous endophthalmitis identified swollen eyelids and ocular pain as critical red flags for poor prognosis, with Klebsiella pneumoniae infection being the strongest predictor of both visual loss and globe loss.
ANTIBIOTIC PROPHYLAXIS FOR PREVENTING ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTIONS: An Updated Systematic Review and Meta-analysis.
Aleksander-Ivanov, Cheidde & Zago Filho
Retina·Apr 1, 2026
This systematic review and meta-analysis of over 5.8 million intravitreal injections found that topical antibiotic prophylaxis does not reduce endophthalmitis risk and may actually increase risk in patients receiving anti-VEGF injections.
Special AAO Report: Recommendations on Screening for Hydroxychloroquine Retinopathy (2025 Revision).
Marmor, Ahn …
Ophthalmology·Apr 1, 2026
The 2025 AAO revision updates hydroxychloroquine retinopathy screening recommendations, emphasizing OCT and fundus autofluorescence as primary screening tools with baseline examination recommended soon after HCQ initiation.
Comparative Analysis of Ocular Adverse Events between Aflibercept 8 mg and Faricimab: A Global Population-Based Study across 65 Countries.
Lakhani, Popovic … Hurley
Ophthalmol Retina·Apr 1, 2026
This global pharmacovigilance study analyzing 30,761 FAERS reports revealed distinct ocular safety profiles for different anti-VEGF agents: aflibercept 8mg showed highest risk for intraocular inflammation and endophthalmitis, faricimab for injection-related inflammatory events, and aflibercept 2mg for structural complications.
ASSOCIATION BETWEEN ANTIBIOTIC PROPHYLAXIS AND ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION: A Systematic Review and Meta-Analysis.
Liu, Li … Song
Retina·Apr 1, 2026
This systematic review and meta-analysis of over 3 million intravitreal injections found no significant reduction in endophthalmitis rates with topical antibiotic prophylaxis compared to no prophylaxis, leading authors to recommend against routine antibiotic use.
Maculopathy in Paclitaxel Users: Nationwide Drug Use, Incidence, and Risk Factors.
Hwang, Kim … Ahn
Ophthalmol Retina·Mar 30, 2026
This nationwide South Korean cohort study of 98,246 paclitaxel users found a 1.4% cumulative incidence of macular edema and/or cystic maculopathy, with a 4-fold increased risk compared to pre-treatment periods.
Visual and Anatomic Outcomes in Delayed-Onset Endophthalmitis After Glaucoma Surgery: A 10-Year Case Series.
Besalti Ekinci, Ozcaliskan … Artunay
Ocul Immunol Inflamm·Mar 30, 2026
Early pars plana vitrectomy within 24 hours of diagnosis achieved significant visual improvement and 100% anatomical success in 15 cases of delayed-onset endophthalmitis following glaucoma surgery over a 10-year period.